Augmedics Gains FDA Clearance for CT-Fluoro Registration
The xvision CT-to-fluoroscopy (CT-Fluoro) registration method allows surgeons to navigate off a preoperative CT scan and fluoroscopic images from a...
Nov 19, 2024,
Augmedics Gains FDA Clearance for CT-Fluoro Registration
Zimmer Biomet Gains CE Mark for Persona Revision Knee
Persona Revision offers a personalized fit and optimized function for patients undergoing revision knee surgery. ...
Nov 18, 2024,
THINK Surgical Gains 510(k) for LinkSymphoKnee Implants with TMINI
LinkSymphoKnee is added to THINK Surgical's ID-HUB data bank of implant modules for use with the open platform version of...
Nov 18, 2024,
Locate Bio Launches LDGraft RESTORE Study
LDGraft is a combination product that delivers recombinant human bone morphogenetic protein-2 through a biodegradable polymer....
Nov 18, 2024,
Study Demonstrates Advantages of Nevro1 SI Joint Fusion
Nevro1 is an FDA 510(k)-cleared device intended to transfix the SI joint for immediate stability and long-term fusion. ...
Nov 18, 2024,
Osteal Therapeutics Reports Positive Study Results
Two prospective, randomized, comparative studies evaluated the efficacy of a rapid exchange arthroplasty with intra-articular antibiotic irrigation vs. two-stage exchange...
Nov 18, 2024,
Mid-Tier Growth Companies Maintain Torrid Pace in 2024
We examine the 2024 performance of three companies among the fastest-growing in orthopedics: Treace Medical, Paragon 28 and OrthoPediatrics....
Nov 18, 2024,
Bolt Navigation Announces Spine Navigation Platform 2.0 Release
Bolt 2.0 leverages Apple’s latest iOS platform and includes UI enhancements that further streamline the surgical workflow....
Nov 15, 2024,
J&J MedTech Announces Strategic Agreement with Responsive Arthroscopy
J&J MedTech entered an exclusive U.S. commercial distribution agreement with Responsive Arthroscopy, enhancing its soft tissue portfolio....
Nov 15, 2024,
Paragon 28 Relies on Broad Portfolio to Offset Market Choppiness
The company grew in the high-teens in the third quarter of 2024, as its wide-ranging portfolio insulated it from market...
Nov 14, 2024,
Loading new posts...
No more posts
